Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery

Status:
Not yet recruiting

Trial end date:
2021-04-01

Target enrollment:

Participant gender:

To monitor intraocular pressure in glaucoma patients after cataract surgery preformed in conjunction with minimally invasive glaucoma surgery (MIGS)

Phase 4

Cathleen McCabe MD

Ocular Therapeutix, Inc.

Dexamethasone
Difluprednate